secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001213900-23-071031
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali SPAC Holdco secures $18M Series A Preferred investment from FutureTech Capital for business combination
--------------------------------------------------------------------------------

- FutureTech Capital commits to purchase 1.8M shares of Series A Convertible Preferred Stock at $10/share ($18M total).
- Closing contingent on concurrent consummation of business combination with Longevity Biomedical.
- Preferred stock convertible into common at lower of $8.00 or 80% of 20-day VWAP, with $5.00 floor conversion price.
- Holders vote with common on as-converted basis and receive dividends as paid on common shares.
- Post-combination entity expected to list on Nasdaq as LBIO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023071031/0001213900-23-071031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023071031/ea184258-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-071031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer